Related Experiment Videos
Skin microcirculation in peripheral arterial obliterative disease.
1Department of Internal Medicine, University of Pisa, Via Roma 67, 56100 Pisa, Italy. mrossi@int.med.unipi.it
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|October 7, 2004
Summary
Peripheral arterial obliterative disease (PAOD) involves microcirculation changes. Early adaptation and later deterioration of skin microcirculation are key indicators in PAOD stages, aiding patient management.
Area of Science:
- Vascular Medicine
- Dermatology
- Medical Physiology
Background:
- Microcirculation plays a crucial role in peripheral arterial obliterative disease (PAOD) pathophysiology and symptoms.
- Non-invasive techniques like capillaroscopy, laser Doppler (LD) fluxmetry, and transcutaneous oxygen tension (tcPO2) measurement have advanced PAOD research.
Purpose of the Study:
- To investigate the role of skin microcirculation in different stages of PAOD.
- To analyze microcirculatory adaptations and deteriorations using advanced non-invasive methods.
Main Methods:
- Utilized capillaroscopy, laser Doppler (LD) fluxmetry, and transcutaneous oxygen tension (tcPO2) measurements.
- Analyzed basal and post-ischemic skin perfusion and flowmotion in PAOD patients.
- Assessed endothelial, neurogenic, myogenic, and sympathetic activities through spectral analysis of LD tracings.
Main Results:
- Stage II PAOD patients show normal basal skin perfusion but abnormal flowmotion, indicating early microcirculatory adaptation.
- Post-ischemia, stage II PAOD patients exhibit impaired hyperemia and reduced capillary blood flow.
- Critical limb ischemia (CLI) demonstrates advanced microcirculatory deterioration, with severely impaired hyperemia, reduced tcPO2, and perturbed skin flowmotion.
Conclusions:
- Skin microcirculation is significantly altered in PAOD, with distinct changes observed in stage II and critical limb ischemia.
- An integrated diagnostic approach using microcirculatory parameters can improve PAOD patient management.